ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2156

IL-6 and TNF-α Modulate Expressions of Cell Cycle Regulators of Rheumatoid Arthritis Fibroblast-like Synoviocytes

Kenta Kaneshiro1, Teppei Hashimoto2, Kohsuke Yoshida1, Ayako Nakai1, Naonori Hashimoto1, Kohjin Suzuki1, Koto Uchida1, Yoshiko Kawasaki2, Natsuko Nakagawa3, Nao Shibanuma4, Yoshitada Sakai5 and Akira Hashiramoto6, 1Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan, 2Department of Rheumatology, Kobe Kaisei Hospital, Kobe, Japan, 3Department of Orthopaedic Surgery, Konan-Kakogawa Hospital, Kakogawa, Japan, 4Departmant of Orthopaedic Surgery, Kobe Kaisei Hospital, Kobe, Japan, 5Division of Rehabilitation Medicine, Kobe University Graduate School of Medicine, Kobe, Japan, 6Department of Biophysics, Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: cytokines, rheumatoid arthritis (RA) and synovial cells, synovial fluid

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:   Iinterleukin(IL)-6 and tumor necrosis factor(TNF)-α play important roles in the pathogenesis of RA, however, it remains unclear how they affect or modulate the cell cycle of Rheumatoid Arthritis Fibroblast-Like Synoviocyte (RA-FLS). Cyclins, Cyclin-Dependent Kinases (CDKs) and CDK inhibitors (CDKIs) co-operate to regulate the cell cycle, and several conditions such as replicative senescence, irradiation, low serum culture and high cellular density culture are reported to induce the expression of CDKIs, including INK4 family and Cip/Kip family, resulting in inhibiting the growth of RA-FLS (Rheumatoid Arthritis Fibroblast-Like Synoviocyte) (1). In this study, we investigated the expression of Cell Cycle regulators under stimulations of IL-6 and TNF-α.

Methods:   Under stimulations of IL-6/ soluble IL-6 receptor (100 ng/ml) or TNF-α (10ng/ml), total RNA and protein were extracted from RA-FLS to analyze expressions of CDK inhibitors(p16 INK4a , p21 Cip1 and p27 Kip1) by real-time PCR, and Cyclin D1 by Western Blot, respectively.

Results:   Expressions of p16 INK4a was decreased by IL-6 stimulation and p27 Kip1 was increased by TNF-α, whereas p21 Cip1 was not changed. The expression of Cyclin D1 was increased by both of IL-6 and TNF-α.

Conclusion: In RA-FLS, IL-6 and TNF-α modulate the expression of p16 INK4a , p27 Kip1 genes, and induce the expression of Cyclin D1. Our results suggest IL-6 and TNF-α co-operate to drive the G1 to S phase transition in the cell cycle of RA-FLS. Reference: 1. Ken Taniguchi et al. nature medicine 1999 Jul;5(7):760-7.


Disclosure: K. Kaneshiro, None; T. Hashimoto, None; K. Yoshida, None; A. Nakai, None; N. Hashimoto, None; K. Suzuki, None; K. Uchida, None; Y. Kawasaki, None; N. Nakagawa, None; N. Shibanuma, None; Y. Sakai, None; A. Hashiramoto, None.

To cite this abstract in AMA style:

Kaneshiro K, Hashimoto T, Yoshida K, Nakai A, Hashimoto N, Suzuki K, Uchida K, Kawasaki Y, Nakagawa N, Shibanuma N, Sakai Y, Hashiramoto A. IL-6 and TNF-α Modulate Expressions of Cell Cycle Regulators of Rheumatoid Arthritis Fibroblast-like Synoviocytes [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/il-6-and-tnf-%ce%b1-modulate-expressions-of-cell-cycle-regulators-of-rheumatoid-arthritis-fibroblast-like-synoviocytes/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/il-6-and-tnf-%ce%b1-modulate-expressions-of-cell-cycle-regulators-of-rheumatoid-arthritis-fibroblast-like-synoviocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology